Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfar S Azmi

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Biochimica Et Biophysica Acta|May 4, 2010
Emerging roles of PDGF-D signaling pathway in tumor development and progressionZhiwei Wang, Aamir Ahmad, Yiwei Li, et al.
Biochimica Et Biophysica Acta|July 6, 2010
Targeting Notch signaling pathway to overcome drug resistance for cancer therapyZhiwei Wang, Yiwei Li, Aamir Ahmad, et al.
Nature Reviews. Gastroenterology & Hepatology|November 25, 2010
Pancreatic cancer: understanding and overcoming chemoresistanceZhiwei Wang, Yiwei Li, Aamir Ahmad, et al.
Seminars in Cancer Biology|June 19, 2007
Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer propertiesS M Hadi, Showket H Bhat, Asfar S Azmi, et al.
International Journal of Cancer|September 9, 2010
Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivoSanjeev Banerjee, Dejuan Kong, Asfar S Azmi, et al.
Toxicology|May 20, 2008
The anthocyanidin delphinidin mobilizes endogenous copper ions from human lymphocytes leading to oxidative degradation of cellular DNASarmad Hanif, Uzma Shamim, M F Ullah, et al.
Free Radical Research|July 29, 2008
Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanismUzma Shamim, Sarmad Hanif, M F Ullah, et al.
Mini Reviews in Medicinal Chemistry|April 10, 2010
MDM2 inhibitors for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Khaldoun Almhanna, et al.
Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.
Cancer Treatment Reviews|February 5, 2020
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?Misako Nagasaka, Yiwei Li, Ammar Sukari, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Biochimica Et Biophysica Acta|May 4, 2010
Emerging roles of PDGF-D signaling pathway in tumor development and progressionZhiwei Wang, Aamir Ahmad, Yiwei Li, et al.
Biochimica Et Biophysica Acta|July 6, 2010
Targeting Notch signaling pathway to overcome drug resistance for cancer therapyZhiwei Wang, Yiwei Li, Aamir Ahmad, et al.
Nature Reviews. Gastroenterology & Hepatology|November 25, 2010
Pancreatic cancer: understanding and overcoming chemoresistanceZhiwei Wang, Yiwei Li, Aamir Ahmad, et al.
Seminars in Cancer Biology|June 19, 2007
Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer propertiesS M Hadi, Showket H Bhat, Asfar S Azmi, et al.
International Journal of Cancer|September 9, 2010
Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivoSanjeev Banerjee, Dejuan Kong, Asfar S Azmi, et al.
Toxicology|May 20, 2008
The anthocyanidin delphinidin mobilizes endogenous copper ions from human lymphocytes leading to oxidative degradation of cellular DNASarmad Hanif, Uzma Shamim, M F Ullah, et al.
Free Radical Research|July 29, 2008
Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanismUzma Shamim, Sarmad Hanif, M F Ullah, et al.
Mini Reviews in Medicinal Chemistry|April 10, 2010
MDM2 inhibitors for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Khaldoun Almhanna, et al.
Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.
Cancer Treatment Reviews|February 5, 2020
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?Misako Nagasaka, Yiwei Li, Ammar Sukari, et al.
Pageof 16